About nanoappsmedical

NanoApps Medical - Official website

Scientific illiteracy – Emerging tech isn’t doing a good enough job ‘explaining’ itself

Nanotechnology is revolutionizing everything from industry to medicine. We live in the most scientifically advanced age of all time, while simultaneously living in a profoundly scientifically-illiterate era, especially in the United States. People used to believe the sun was driven around the Earth by some god in a chariot, but considering what genuine scientific knowledge [...]

By |2021-11-11T13:17:54+00:00November 11th, 2021|Categories: News|0 Comments

People testing negative for Covid-19 despite exposure may have ‘immune memory’

Study says some individuals clear virus rapidly due to a strong immune response from existing T-cells, meaning tests record negative result. We all know that person who, despite their entire household catching Covid-19, has never tested positive for the disease. Now scientists have found an explanation, showing that a proportion of people experience “abortive [...]

By |2021-11-11T12:31:35+00:00November 11th, 2021|Categories: News|0 Comments

Identification of common genes in COVID-19 and COPD

The coronavirus disease 2019 (COVID-19) pandemic has caused several waves of infections in many world regions, so strong as to overwhelm local healthcare services. In this new situation, faced with an unknown virus, the need is to produce clinical guidelines that help recognize and manage critical COVID-19. Meanwhile, conditions such as chronic obstructive pulmonary [...]

By |2021-11-10T08:12:45+00:00November 10th, 2021|Categories: News|0 Comments

COVID-19 Vaccine Patch Does Not Require Cold Chain Transport

Researchers at the University of Queensland and Vaxxas, a medtech company, announced the development of a high-density microarray patch (HD-MAP) that can deliver a COVID-19 vaccine through the skin without the need for needles. While such minimally invasive vaccine technology is to be welcomed, the major breakthrough is the temperature stability of the vaccine. [...]

By |2021-11-10T05:02:06+00:00November 10th, 2021|Categories: News|0 Comments

Exotic magnetic states on the nanoscale

An international research team, led by scientists from the EMPA (Zurich) and the International Iberian Nanotechnology Laboratory, which has researchers from the UPV/EHU, has succeeded in building chains of quantum magnets made of nanographene that capture the essence of one of the core models of quantum magnetism. The team's results (Nature, "Observation of fractional edge excitations in [...]

By |2021-11-08T11:57:18+00:00November 8th, 2021|Categories: News|0 Comments

Scanning a single protein, one amino acid at a time

Using nanopore DNA sequencing technology, researchers from TU Delft and the University of Illinois have managed to scan a single protein: by slowly moving a linearized protein through a tiny nanopore, one amino acid at the time, the researchers were able to read off electric currents that relate to the information content of the [...]

By |2021-11-08T11:18:44+00:00November 8th, 2021|Categories: News|0 Comments

Using DNA Nanolevers to Measure Virus and Peptide Interactions

The bonding interaction amongst Influenza A and the peptide "PeB," which selectively binds the viral surface protein hemagglutinin, has been investigated using electrically controlled deoxyribonuclic acid (DNA) nanolevers in the journal Advanced Materials. PeB is conjugated to DNA strands that are bonded to complementary anchors and fixed on the electrode surface of a "switchSENSE" biochip. [...]

By |2021-11-08T11:06:04+00:00November 8th, 2021|Categories: News|0 Comments

The Future of SARS-CoV-2 Vaccination — Lessons from Influenza

After a period of falling Covid-19 illness rates, the recent spread of the delta variant of SARS-CoV-2 was a major disappointment and necessitated a reexamination of some previous assumptions. This reconsideration may, at least in part, be a correction to overly optimistic views of what highly effective SARS-CoV-2 vaccines could accomplish. Some observers had [...]

By |2021-11-07T12:29:12+00:00November 7th, 2021|Categories: News|0 Comments

Pfizer says its new COVID pill cuts risk of hospitalization and death by almost 90%

Drug giant announced results on Friday Study on 775 COVID patients found pill reduced hospitalization and death rates by 89 per cent compared to patients giving a dummy pill Results of independent study were so impressive Pfizer halted it early to seek approval for its usage It wants the Food and Drug Administration to authorize [...]

By |2021-11-05T12:59:24+00:00November 5th, 2021|Categories: News|0 Comments

Britain approves Merck’s COVID-19 pill in world first

UK approval for molnupiravir comes ahead of U.S. decision UK and NHS to confirm deployment plans in due course UK secured just under half a million courses last month Drug will be given to higher risk patients Approval comes as UK struggles to tame infections Nov 4 (Reuters) - Britain on Thursday became the [...]

By |2021-11-05T11:09:59+00:00November 5th, 2021|Categories: News|0 Comments
Go to Top